查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1661103

子宮內避孕器 (IUD) 市場報告（按產品（荷爾蒙子宮內避孕器、銅子宮內避孕器）、最終用途（醫院、婦科診所、社區醫療保健等）和地區分類）2025 年至 2033 年

Intrauterine Devices (IUD) Market Report by Product (Hormonal Intrauterine Device, Copper Intrauterine Device), End-Use (Hospitals, Gynaecology Clinics, Community Healthcare, and Others), and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球子宮內避孕IMARC Group市場規模達到 47 億美元，2025-2033 年期間的成長率 (CAGR) 為 3.87%。市場發展的推動因素包括：人們對長效可逆避孕 (LARC) 認知的不斷提高、子宮內避孕器設計和插入技術的重大技術進步、以及政府推出的促進計劃生育和避孕措施的有利舉措。

子宮內避孕器（IUD）是一種長期、可逆的避孕方式，是當今最有效的避孕方法之一。 IUD 是一種小型的 T 型裝置，由醫療保健提供者插入子宮以防止懷孕。子宮內避孕器主要有兩種類型：銅子宮內避孕器（會釋放少量銅來阻止精子到達卵子）和荷爾蒙子宮內避孕器（會釋放荷爾蒙來增稠子宮頸黏液並阻止精子使卵子受精）。子宮內避孕器可提供較長的保護期，根據類型的不同，保護期從三年到十年不等。它們提供了最低限度的持續護理的便利，並且因其有效性、可逆性和易用性而受到青睞。

全球市場的主要動力是隨著有效的長期避孕方法的出現，人們對生殖健康的認知不斷提高。同時，人們對可逆且無麻煩的避孕方法的日益偏好也為市場提供了動力。此外，醫療保健提供者和組織對子宮內避孕器的益處和用途的支持和教育舉措正成為推動市場成長的重要因素。此外，由於子宮內避孕器安全性和可靠性，醫療專業人員對其的認可也促進了市場的擴大。此外，政府推動計劃生育和生殖健康教育的措施不斷增多，也對市場產生了正面影響。優惠的醫療政策和保險覆蓋進一步推動了市場的發展，使更廣泛的人群更容易獲得併負擔得起子宮內避孕器。

子宮內避孕器 (IUD) 市場趨勢/促進因素：

人口控制力道不斷加大

永續發展意識的不斷增強，使得各國政府和國際組織都把人口控制工作放在了優先地位。政策方向的重大轉變正在加強子宮內避孕器等有效、長期避孕方法的作用。此外，多個國家的政府機構、非政府組織和製造商之間的各種合作項目也旨在推廣子宮內避孕器作為首選的計劃生育方法。這些聯盟往往會產生廣泛的宣傳活動、分銷網路和教育推廣，使子宮內避孕器更容易被不同人群所接受。此外，各地區採取的針對性干預措施和補貼政策也進一步促進了子宮內避孕器的普及。全球人口控制運動強調負責任的計劃生育和生育選擇，這成為子宮內避孕器市場發展的強大推動力，促進了需求和創新。

女性勞動參與率不斷提高

女性勞動參與率的上升標誌著文化和經濟的轉變，影響生活的各個層面，包括生育選擇。隨著女性不斷承擔起職業角色，對方便、可靠、低維護的避孕方法的需求也日益成長。子宮內避孕器以其持久的效果和極少的持續護理而聞名，非常符合職業婦女的生活方式需求。它們提供了許多人在平衡事業與個人生活時所尋求的靈活性和保證。此外，雇主和醫療保健提供者越來越認知到這些需求，並將子宮內避孕器的支持和保障作為全面健康福利的一部分。這種市場供應與日益成長的人口群體的實際需求一致的現像不僅是一種趨勢，也是子宮內避孕器市場發展的強大驅動力。

醫療技術和研究不斷進步

醫療保健產業的特點是醫療技術和研究的不斷進步，避孕領域也不例外。材料、設計和激素輸送機制的創新導致了更先進、更方便用戶使用的子宮內避孕器的開發。改進的動力源於該領域領先公司對研發的投資，這些投資通常與醫療保健提供者和研究機構合作。這些合作關係使人們能夠更深入地了解使用者的需求、偏好和醫療要求，從而指導新 IUD 模型的設計和功能。這種對創新的關注確保了子宮內避孕器始終處於避孕技術的前沿，提供不僅有效且符合使用者舒適度和健康的選擇。對技術進步的投資強調了對增強生殖健康的承諾，使其成為子宮內避孕器市場成長的關鍵驅動力。

目錄

第 1 章：前言

第 2 章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球子宮內避孕器市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場區隔：按產品
  • 市場區隔：最終用途別
  • 市場分佈：按地區
  • 市場預測
  • SWOT 分析
    • 概述
    • 優勢
    • 弱點
    • 機會
    • 威脅
  • 價值鏈分析
    • 概述
    • 研究與開發
    • 原物料採購
    • 製造業
    • 行銷
    • 分配
    • 最終用途
  • 波特五力分析
    • 概述
    • 買家的議價能力
    • 供應商的議價能力
    • 競爭程度
    • 新進入者的威脅
    • 替代品的威脅

第6章：市場區隔：依產品

  • 荷爾蒙子宮內避孕器
    • 市場趨勢
    • 市場預測
  • 銅子宮內避孕器
    • 市場趨勢
    • 市場預測

第 7 章：市場區隔：最終用途別

  • 醫院
    • 市場趨勢
    • 市場預測
  • 婦科診所
    • 市場趨勢
    • 市場預測
  • 社區醫療保健
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：按地區

  • 歐洲
    • 市場趨勢
    • 市場預測
  • 北美洲
    • 市場趨勢
    • 市場預測
  • 亞太地區
    • 市場趨勢
    • 市場預測
  • 中東和非洲
    • 市場趨勢
    • 市場預測
  • 拉丁美洲
    • 市場趨勢
    • 市場預測

第 9 章：子宮內避孕器製造過程

  • 產品概述
  • 原料需求
  • 製造過程
  • 關鍵成功因素與風險因素

第 10 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Actavis
    • Bayer
    • Teva Pharmaceuticals
    • Allergan
    • ANI Pharmaceuticals
    • Eurogine
    • OCON Medical
    • Pregna
    • SMB Corporation
    • HLL Lifecare
    • HRA Pharma
    • Besins HealthCare
Product Code: SR112025A954

The global intrauterine devices market size reached USD 4.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 6.8 Billion by 2033, exhibiting a growth rate (CAGR) of 3.87% during 2025-2033. The market is propelled by the rising awareness about long-acting reversible contraception (LARC), significant technological advancements in IUD design and insertion techniques, favorable government initiatives promoting family planning and contraception access.

Intrauterine Devices (IUDs) are a form of long-term, reversible birth control, representing one of the most effective contraceptive methods available today. An IUD is a small, T-shaped device that is inserted into the uterus by a healthcare provider to prevent pregnancy. There are two main types of IUDs: copper IUDs, which release a small amount of copper to deter sperm from reaching the egg, and hormonal IUDs, which release hormones to thicken cervical mucus and block sperm from fertilizing the egg. IUDs provide an extended period of protection, ranging from three to ten years, depending on the type. They offer the convenience of minimal ongoing care and are favored for their efficacy, reversibility, and ease of use.

The global market is primarily driven by the increasing awareness about reproductive health facilitated by the availability of effective, long-term contraceptive methods. In line with this, the growing preference for reversible and hassle-free birth control options is also providing an impetus to the market. Moreover, the support and educational initiatives by healthcare providers and organizations about the benefits and usage of IUDs are acting as significant growth-inducing factors for the market. In addition to this, the endorsement of IUDs by medical professionals, owing to their safety and reliability, is encouraging the expansion of the market. Also, the rise in government initiatives promoting family planning and reproductive health education is impacting the market positively. The market is further driven by favorable healthcare policies and insurance coverage, which make IUDs more accessible and affordable to a broader population.

Intrauterine Devices (IUD) Market Trends/Drivers:

Rising trend of population control efforts

The growing awareness of sustainable development has led governments and international organizations to prioritize population control efforts. This significant shift in policy direction is reinforcing the role of effective and long-term contraceptive methods such as IUDs. Also, various collaborative programs among governmental bodies of several countries, NGOs, and manufacturers aim to promote IUDs as a preferred method of family planning. These alliances often result in extensive campaigns, distribution networks, and educational outreach, making IUDs more accessible and acceptable to diverse populations. Additionally, tailored interventions and subsidies in various regions further facilitate the adoption of IUDs. This global movement towards population control, with an emphasis on responsible family planning and reproductive choices, stands as a powerful driver for the IUD market, fueling both demand and innovation.

Growing female workforce participation

The rise in the female workforce's participation marks a cultural and economic shift, influencing various aspects of life, including reproductive choices. As women continue to take on professional roles, the need for convenient, reliable, and low-maintenance contraceptive methods has grown. IUDs, known for their extended effectiveness and minimal ongoing care, resonate with the lifestyle needs of working women. They provide the flexibility and assurance that many seek in balancing their careers and personal lives. Moreover, employers and healthcare providers are increasingly recognizing these needs, offering support and coverage for IUDs as part of comprehensive health benefits. This alignment of market supply with the real-life demands of a growing segment of the population is not just a trend but a substantial driving force in the IUD market.

Continual advancements in medical technology and research

The healthcare industry is marked by continuous advancements in medical technology and research, and the field of contraception is no exception. Innovations in materials, designs, and hormone delivery mechanisms have led to the development of more advanced and user-friendly IUDs. The drive for improvement is fueled by investment in research and development by leading companies in the field, often in collaboration with healthcare providers and research institutions. These partnerships enable a deeper understanding of user needs, preferences, and medical requirements, guiding the design and functionality of new IUD models. This focus on innovation ensures that IUDs remain at the forefront of contraceptive technology, offering choices that are not only effective but also aligned with the comfort and well-being of users. The investment in technological progress underscores the commitment to enhancing reproductive health, making it a pivotal driver in the IUD market growth.

Intrauterine Devices (IUD) Industry Segmentation:

Breakup by Product:

  • Hormonal Intrauterine Device
  • Copper Intrauterine Device

Hormonal intrauterine device (IUD) represents the largest market segment

The demand for hormonal IUDs is growing due to their high effectiveness in preventing pregnancies, which makes them a reliable choice for many. Their suitability for extended usage of up to 3-7 years offers long-term solutions without the need for daily intervention. The ability to return to normal fertility after removal adds to their appeal. Many users also find them to be a preferable non-surgical option, contributing to their popularity. The combined factors of effectiveness, longevity, reversibility, and non-surgical nature make this segment an integral part of the global IUD market.

On the other hand, copper IUDs offer a contraceptive method without the use of hormones, appealing to those who want to avoid hormonal intervention. They provide a cost-effective solution, often entailing only a one-time expense. The protection they offer is long-lasting, often effective for up to 10 years, making them an attractive long-term option. These factors together make copper IUDs a significant segment, reflecting the various preferences and financial considerations of the global population.

Breakup by End-Use:

  • Hospitals
  • Gynaecology Clinics
  • Community Healthcare
  • Others

In the hospitals segment, the availability of specialized professionals ensures access to expert care, while the use of modern tools and technologies facilitates insertion. Comprehensive services, including consultation, insertion, and follow-up, create a streamlined patient experience. Hospitals continue to be a core setting for IUD administration, integrating specialized care with state-of-the-art technology to serve a broad population base.

On the other hand, gynaecology clinics are seeing growth in IUD administrations owing to their focused expertise in women's reproductive health. They offer personalized care tailored to individual needs and are often more accessible than hospitals for many patients. This specialized, accessible, and personalized care makes gynaecology clinics an essential part of the landscape, serving a diverse clientele with varying needs and preferences.

Furthermore, community healthcare segment of the market is impelled by the introduction of affordable and often lower-cost services. Accessibility in remote and underserved areas ensures that more people can avail themselves of these devices. Education and outreach are significant components of this segment, with community health providers offering necessary information and support. This approach fosters a wider reach and makes IUDs available to populations that might otherwise have limited access.

Breakup by Region:

  • Europe
  • North America
  • Asia Pacific
  • Middle East and Africa
  • Latin America

North America exhibits a clear dominance, accounting for the largest intrauterine devices (IUD) market share

The report has also provided a comprehensive analysis of all the major regional markets, which include Europe, North America, Asia Pacific, Middle East and Africa, and Latin America. According to the report, North America accounted for the largest market share.

The North America region's IUD market is driven by several factors, forming a complex and synergistic landscape that fosters growth. The well-developed healthcare infrastructure ensures robust availability and service delivery, making both hormonal and copper IUDs accessible to a wide range of the population.

Regulatory support in this region fosters a generally favorable environment for IUDs, with clear guidelines and standards that help maintain quality and safety. Economic factors, particularly higher income levels, facilitate more accessible healthcare services, allowing for a broader spectrum of the population to avail themselves of this contraceptive method. These financial considerations also support ongoing research and development in the field, leading to potential innovations and improvements in IUD technology.

The positively changing cultural attitudes towards reproductive health is contributing to a more open dialogue and acceptance of various contraceptive options, including IUDs. The integration of advanced medical practices and continual professional development among healthcare providers further enhances the region's ability to offer state-of-the-art care.

Competitive Landscape:

The leading companies are investing in research and development (R&D) activities to create new and improved IUDs. These innovations often focus on enhancing effectiveness, reducing side effects, and increasing user comfort. The key players are also exploring new markets and expanding into emerging economies to utilize opportunities in areas where contraceptive methods like IUDs may be less prevalent. To enhance awareness and acceptance of IUDs, the major companies are engaging in educational campaigns by working with healthcare providers and community organizations to provide accurate product information. Furthermore, the top players are working closely with regulatory bodies to ensure that their products comply with local laws and guidelines, maintaining quality and safety. Apart from this, they are also diversifying their portfolio and offering products at various price points, to make IUDs accessible to a broader range of income levels.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Actavis
  • Bayer
  • Teva Pharmaceuticals
  • Allergan
  • ANI Pharmaceuticals
  • Eurogine
  • OCON Medical
  • Pregna
  • SMB Corporation
  • HLL Lifecare
  • HRA Pharma
  • Besins HealthCare

Key Questions Answered in This Report

  • 1.What was the size of the global intrauterine devices market in 2024?
  • 2.What is the expected growth rate of the global intrauterine devices market during 2025-2033?
  • 3.What are the key factors driving the global intrauterine devices market?
  • 4.What has been the impact of COVID-19 on the global intrauterine devices market?
  • 5.What is the breakup of the global intrauterine devices market based on the product?
  • 6.What are the key regions in the global intrauterine devices market?
  • 7.Who are the key players/companies in the global intrauterine devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Intrauterine Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Product
  • 5.5 Market Breakup by End-Use
  • 5.6 Market Breakup by Region
  • 5.7 Market Forecast
  • 5.8 SWOT Analysis
    • 5.8.1 Overview
    • 5.8.2 Strengths
    • 5.8.3 Weaknesses
    • 5.8.4 Opportunities
    • 5.8.5 Threats
  • 5.9 Value Chain Analysis
    • 5.9.1 Overview
    • 5.9.2 Research and Development
    • 5.9.3 Raw Material Procurement
    • 5.9.4 Manufacturing
    • 5.9.5 Marketing
    • 5.9.6 Distribution
    • 5.9.7 End-Use
  • 5.10 Porters Five Forces Analysis
    • 5.10.1 Overview
    • 5.10.2 Bargaining Power of Buyers
    • 5.10.3 Bargaining Power of Suppliers
    • 5.10.4 Degree of Competition
    • 5.10.5 Threat of New Entrants
    • 5.10.6 Threat of Substitutes

6 Market Breakup by Product

  • 6.1 Hormonal Intrauterine Device
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Copper Intrauterine Device
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by End-Use

  • 7.1 Hospitals
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Gynaecology Clinics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Community Healthcare
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Region

  • 8.1 Europe
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 North America
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Asia Pacific
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Middle East and Africa
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Latin America
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Intrauterine Devices Manufacturing Process

  • 9.1 Product Overview
  • 9.2 Raw Material Requirements
  • 9.3 Manufacturing Process
  • 9.4 Key Success and Risk Factors

10 Competitive Landscape

  • 10.1 Market Structure
  • 10.2 Key Players
  • 10.3 Profiles of Key Players
    • 10.3.1 Actavis
    • 10.3.2 Bayer
    • 10.3.3 Teva Pharmaceuticals
    • 10.3.4 Allergan
    • 10.3.5 ANI Pharmaceuticals
    • 10.3.6 Eurogine
    • 10.3.7 OCON Medical
    • 10.3.8 Pregna
    • 10.3.9 SMB Corporation
    • 10.3.10 HLL Lifecare
    • 10.3.11 HRA Pharma
    • 10.3.12 Besins HealthCare

List of Figures

  • Figure 1: Global: Intrauterine Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Intrauterine Devices Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Intrauterine Devices Market: Breakup by Product (in %), 2024
  • Figure 4: Global: Intrauterine Devices Market: Breakup by End-Use (in %), 2024
  • Figure 5: Global: Intrauterine Devices Market: Breakup by Region (in %), 2024
  • Figure 6: Global: Intrauterine Devices Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 7: Global: Intrauterine Devices Industry: SWOT Analysis
  • Figure 8: Global: Intrauterine Devices Industry: Value Chain Analysis
  • Figure 9: Global: Intrauterine Devices Industry: Porter's Five Forces Analysis
  • Figure 10: Global: Intrauterine Devices (Hormonal) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Intrauterine Devices (Hormonal) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Intrauterine Devices (Copper) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Intrauterine Devices (Copper) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Intrauterine Devices (End-Use in Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Intrauterine Devices (End-Use in Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Intrauterine Devices (End-Use in Gynaecology Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Intrauterine Devices (End-Use in Gynaecology Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Intrauterine Devices (End-Use in Community Healthcare) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Intrauterine Devices (End-Use in Community Healthcare) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Intrauterine Devices (Other End-Uses) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Intrauterine Devices (Other End-Uses) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Europe: Intrauterine Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Europe: Intrauterine Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: North America: Intrauterine Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: North America: Intrauterine Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Asia Pacific: Intrauterine Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Asia Pacific: Intrauterine Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Middle East and Africa: Intrauterine Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Middle East and Africa: Intrauterine Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Latin America: Intrauterine Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Latin America: Intrauterine Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Intrauterine Devices Manufacturing: Detailed Process Flow

List of Tables

  • Table 1: Global: Intrauterine Devices Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Intrauterine Devices Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Intrauterine Devices Market Forecast: Breakup by End-Use (in Million USD), 2025-2033
  • Table 4: Global: Intrauterine Devices Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 5: Intrauterine Devices Manufacturing: Raw Material Requirements
  • Table 6: Global: Intrauterine Devices Market: Competitive Structure
  • Table 7: Global: Intrauterine Devices Market: Key Players